SCHEMBL12424334

SCHEMBL12424334

CC1CCc2cn[nH]c2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
PRKACA P17612 2/20 0.42
KDR P35968 2/20 0.42
CDK8 P49336 2/20 0.42
CDK9 P50750 2/20 0.42
ROCK1 Q13464 2/20 0.42
CLK4 Q9HAZ1 2/20 0.42
DYRK1B Q9Y463 2/20 0.42
DAPK3 O43293 1/20 0.42
JAK2 O60674 1/20 0.42
CSF1R P07333 1/20 0.42
RET P07949 1/20 0.42
LTK P29376 1/20 0.42
GRK5 P34947 1/20 0.42
MAP2K2 P36507 1/20 0.42
MAPK8 P45983 1/20 0.42
CSNK1A1 P48729 1/20 0.42
CLK2 P49760 1/20 0.42
GSK3A P49840 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26242979 1.00 DRD2 (0.43) DRD2DRD3PRKACAKDRCDK8
SCHEMBL26242978 1.00 DRD2 (0.43) DRD2DRD3PRKACAKDRCDK8
SCHEMBL15014504 0.85 PRKACA (0.54) DRD2DRD3PRKACAKDRCDK8
SCHEMBL16124191 0.85 PRKACA (0.54) DRD2DRD3PRKACAKDRCDK8
SCHEMBL17485781 0.85 PRKACA (0.54) DRD2DRD3PRKACAKDRCDK8
SCHEMBL23642562 0.77 PRKACA (0.42) DRD2DRD3PRKACAKDRCDK8
SCHEMBL2206646 0.77 DAPK3 (0.42) DRD2DRD3PRKACAKDRCDK8
SCHEMBL19768751 0.77 DRD2 (0.43) DRD2DRD3PRKACAKDRCDK8
SCHEMBL12385832 0.77 DRD2 (0.40) DRD2DRD3PRKACAKDRCDK8
SCHEMBL12384649 0.77 DRD2 (0.40) DRD2DRD3PRKACAKDRCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373950-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. 2023-11-23 US disclosed
US-20230295111-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. 2023-09-21 US disclosed
WO-2023178181-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2023-09-21 WO disclosed
EP-4245756-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF Gilead Sciences, Inc. (US) 2023-09-20 EP disclosed
US-8461328-B2 Tricyclic heterocyclic compounds, compositions and methods of use thereof GENENTECH, INC. (US) 2013-06-11 US disclosed
US-20110201593-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373950-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF IKZF2, IKZF1, IKZF3 DRD2 4825/4885DRD3 4818/4885PRKACA 1789/4885
US-20110201593-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF CCNY, CCNA1, CCNA2 DRD2 3564/4885DRD3 3022/4885PRKACA 807/4885
US-20230295111-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF IKZF2, IKZF1, IKZF3 DRD2 4825/4885DRD3 4818/4885PRKACA 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.